PerspectiveCancer

mTORC1 Status Dictates Tumor Response to Targeted Therapeutics

See allHide authors and affiliations

Science Signaling  24 Sep 2013:
Vol. 6, Issue 294, pp. pe31
DOI: 10.1126/scisignal.2004632

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling

Navigate This Article